Antibodies against g-csfr and uses thereof
US-2025051462-A1 · Feb 13, 2025 · US
This page is not indexed by search engines while we improve data quality.
Panousis Con patents
Panousis Con is listed as an inventor on 41 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Panousis Con |
| Total patents | 41 |
| First publication | May 28, 2015 |
| Latest publication | Feb 13, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Nucleic acids encoding antibodies against human granulocyte-colony stimulating factor receptor (G-CSFR) and method of expressing encoded protein
US-12071484-B2 · Aug 27, 2024 · US
Cd131 binding proteins and uses thereof
US-2024174757-A1 · May 30, 2024 · US
Methods of treating neoplastic astrocytoma
US-2024117073-A1 · Apr 11, 2024 · US
CD131 binding proteins and uses thereof
US-11840573-B2 · Dec 12, 2023 · US
Human serum albumin variants and uses thereof
US-2023086472-A1 · Mar 23, 2023 · US
Use of a FXIIa-inhibitor in the treatment of renal fibrosis and/or chronic kidney disease
US-11505619-B2 · Nov 22, 2022 · US
Human serum albumin variants and uses thereof
US-11466073-B2 · Oct 11, 2022 · US
Method of inhibiting or activating gamma delta t cells
US-2022273713-A1 · Sep 1, 2022 · US
Methods of administering inhibitory anti-factor XII/XIIa monoclonal antibodies
US-11345759-B2 · May 31, 2022 · US
Recent patents
Latest publications not already listed above.
Coagulation factor binding proteins and uses thereof
US-2022089778-A1 · Mar 24, 2022 · US
Method of treating atherosclerosis
US-2022017638-A1 · Jan 20, 2022 · US
Method of treating atherosclerosis
US-11174321-B2 · Nov 16, 2021 · US
Method of treating cancer
US-2021292411-A1 · Sep 23, 2021 · US
Use of a fxiia-inhibitor in the treatment of renal fibrosis and/or chronic kidney disease
US-2021070879-A1 · Mar 11, 2021 · US
Methods of treating neoplastic astrocytoma
US-2021032366-A1 · Feb 4, 2021 · US
Antibodies against g-csfr and uses thereof
US-2021009701-A1 · Jan 14, 2021 · US
Human serum albumin variants and uses thereof
US-2020325209-A1 · Oct 15, 2020 · US
Methods of administering inhibitory anti-factor xii/xiia monoclonal antibodies
US-2020062863-A1 · Feb 27, 2020 · US
Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodies
US-10513560-B2 · Dec 24, 2019 · US
Method of treating atherosclerosis
US-2019309089-A1 · Oct 10, 2019 · US
Coagulation factor binding proteins and uses thereof
US-2019248920-A1 · Aug 15, 2019 · US
Antibodies against g-csfr and uses thereof
US-2019055313-A1 · Feb 21, 2019 · US
Method of treating cancer
US-2019023783-A1 · Jan 24, 2019 · US
Humanized anti-interleukin 3 receptor alpha chain antibodies
US-10047161-B2 · Aug 14, 2018 · US
Methods of administering inhibitory anti-factor xii/xiia monoclonal antibodies
US-2018134806-A1 · May 17, 2018 · US
Methods of treating meningioma
US-2018057606-A1 · Mar 1, 2018 · US
Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodies
US-9856326-B2 · Jan 2, 2018 · US
Nucleic acids encoding inhibitory anti-factor XII/XIIa monoclonal antibodies
US-9856325-B2 · Jan 2, 2018 · US
Compositions and methods for targeting type 1 interferon producing cells
US-9758585-B2 · Sep 12, 2017 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Csl Ltd | 36 |
| Csl Behring Gmbh | 9 |
| Ludwig Inst For Cancer Res Ltd | 4 |
| Ludwig Inst For Cancer Res Ltd | 3 |
| Panousis Con | 3 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K2039/505 | 34 |
| C07K2317/76 | 32 |
| C07K2317/92 | 27 |
| C07K2317/21 | 25 |
| C07K2317/55 | 23 |